BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38459755)

  • 21. Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.
    Peitzsch M; Mangelis A; Eisenhofer G; Huebner A
    Clin Chim Acta; 2019 Jul; 494():100-105. PubMed ID: 30904545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reference intervals for deconjugated urine metanephrines by Bhattacharya analysis.
    Li B; King R; Sies C; Thompson S; Florkowski C
    Ann Clin Biochem; 2024 May; 61(3):173-181. PubMed ID: 37710976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy.
    Liu L; Xie W; Song Z; Wang T; Li X; Gao Y; Li Y; Zhang J; Guo X
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):132-138. PubMed ID: 34486152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma.
    Gardet V; Gatta B; Simonnet G; Tabarin A; Chêne G; Ducassou D; Corcuff JB
    J Hypertens; 2001 Jun; 19(6):1029-35. PubMed ID: 11403350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine.
    Peitzsch M; Novos T; Kaden D; Kurlbaum M; van Herwaarden AE; Müller D; Adaway J; Grouzmann E; McWhinney B; Hoad K; Woollard G; Kema I; Boot C; Fassnacht M; Sweep F; Loh TP; Horvath AR; Eisenhofer G
    Clin Chem; 2021 Aug; 67(8):1098-1112. PubMed ID: 33993248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
    Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma-free vs deconjugated metanephrines for diagnosis of phaeochromocytoma.
    Pamporaki C; Därr R; Bursztyn M; Glöckner S; Bornstein SR; Lenders JW; Pacak K; Krinner A; Eisenhofer G
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):476-83. PubMed ID: 23461656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LC-MS based simultaneous profiling of adrenal hormones of steroids, catecholamines, and metanephrines.
    Noh J; Lee C; Kim JH; Myung SW; Choi MH
    J Lipid Res; 2023 Nov; 64(11):100453. PubMed ID: 37806496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
    Peaston RT; Lennard TW; Lai LC
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases.
    Gerlo EA; Sevens C
    Clin Chem; 1994 Feb; 40(2):250-6. PubMed ID: 7906208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
    Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
    Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors.
    März J; Kurlbaum M; Roche-Lancaster O; Deutschbein T; Peitzsch M; Prehn C; Weismann D; Robledo M; Adamski J; Fassnacht M; Kunz M; Kroiss M
    Front Endocrinol (Lausanne); 2021; 12():722656. PubMed ID: 34557163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
    van Berkel A; Lenders JW; Timmers HJ
    Eur J Endocrinol; 2014 Mar; 170(3):R109-19. PubMed ID: 24347425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
    Därr R; Pamporaki C; Peitzsch M; Miehle K; Prejbisz A; Peczkowska M; Weismann D; Beuschlein F; Sinnott R; Bornstein SR; Neumann HP; Januszewicz A; Lenders J; Eisenhofer G
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):478-86. PubMed ID: 24102244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass.
    Unger N; Pitt C; Schmidt IL; Walz MK; Schmid KW; Philipp T; Mann K; Petersenn S
    Eur J Endocrinol; 2006 Mar; 154(3):409-17. PubMed ID: 16498054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].
    Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of urine catecholamines and metanephrines by reversed-phase liquid chromatography-tandem mass spectrometry].
    Cheuk MY; Lo YC; Poon WT
    Se Pu; 2017 Oct; 35(10):1042-1047. PubMed ID: 29048800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
    Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
    Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between systolic blood pressure reduction during clonidine suppression testing and the decrease in plasma catecholamines and metanephrines.
    Golani T; Fishman B; Sharabi Y; Olswang-Kutz Y; Leibowitz A; Grossman E; Shlomai G
    J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1924-1931. PubMed ID: 32882089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.